Director Jeffrey Kindler Sells 96,686 Shares of Precigen Inc

Published on 12 Jan 2024 on GuruFocus.com via Yahoo Finance

Director Jeffrey Kindler Sells 96,686 Shares of Precigen Inc

On December 28, 2023, Jeffrey Kindler, a Director at Precigen Inc (NASDAQ:PGEN), sold 96,686 shares of the company's stock, according to a recent SEC Filing. Precigen Inc is a biotechnology company that specializes in the development of gene and cell therapies. The company's platform is designed to improve the treatment of cancer and other diseases by controlling gene expression at the cellular level.

Warning! GuruFocus has detected 7 Warning Signs with PGEN.

Over the past year, the insider has sold a total of 96,686 shares and has not made any purchases of the company's stock.

Read the rest of the article

NASDAQ.PGEN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

News

Director Jeffrey Kindler Sells 96,686 Shares of Precigen Inc

NASDAQ.PGEN price evolution

Want to become a better investor?

Earnings call: Precigen eyes transformative 2024 with PRGN-2012 launch By Investing.com

Precigen shares hold with $14 target on pivotal trial focus

Precigen, Inc. (NASDAQ:PGEN) Q4 2023 Earnings Call Transcript

Precigen, Inc.'s (NASDAQ:PGEN) top owners are private equity firms with 38% stake, while 30% is held...

Precigen, Inc. (NASDAQ:PGEN): When Will It Breakeven?

Director Jeffrey Kindler Sells 96,686 Shares of Precigen Inc

Even after rising 15% this past week, Precigen (NASDAQ:PGEN) shareholders are still down 86% over...

Should You Buy Precigen, Inc. (PGEN) After Golden Cross?

Is Precigen (PGEN) Significantly Overvalued? A Comprehensive Valuation Analysis

Is Precigen Inc Set to Underperform? Analyzing the Factors Limiting Growth